Nicotine Dependence
Nicotine dependence is a state of dependence upon nicotine. Nicotine dependence is a chronic, relapsing disease defined as a compulsive craving to use the drug, despite social consequences, loss of control over drug intake, and emergence of withdrawal symptoms. Tolerance is another component of drug dependence.
Cluster Number:
Wiki Number: PW133
Diagnosis: Nicotine Dependence
US Patients:
World Patients: 976 Million Smokers
Sex Ratio:
Age Onset:
Brain Area: Nicotine stimulates receptors in the adrenal medulla and throughout the central and peripheral nervous systems.
Symptoms: Nicotine stimulates brain areas affecting reward, pleasure and anxiety and induce cravings when not involved.
Progression:
Causes: Several genes are involved in dependency; compulsive craving for nicotine despite knowing consequences;
Medications: There are drugs and patches to reduce responsiveness to nicotine.
Therapies: Evidence-Based Medicine increases quitting by 2-3X.
Youttube Video:
The Neurobiology of Addiction-The Reward Pathway
Amazon or Library Book: Nicotine Explained
Click the book to link or buy from Amazon.
Support Group: nicotine-anonymous.org; 877-879-6422
(Nicotine Anonymous)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosisÂ
Clicking each title opens the
PubMed article’s summary-abstract.
- Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Researchby Roger S McIntyre on January 1, 2025
During the past decade, there has been extraordinary public, media, and medical research interest in psychedelics as promising therapeutics for difficult-to-treat psychiatric disorders. Short-term controlled trial data suggest that certain psychedelics are effective and safe in the treatment of major depressive disorder, treatment-resistant depression, and posttraumatic stress disorder. Preliminary evidence also supports efficacy in other psychiatric disorders (e.g., tobacco and alcohol use...
- Patient-specific brain fluorodeoxyglucose positron emission tomography can detect the first effects of combination antiretroviral therapy in patient with HIV infectionby Miyako M Chikanishi on January 1, 2025
Patient-specific brain fluorodeoxyglucose-positron emission tomography (FDG PET) can detect areas with abnormal FDG uptake in patients with human immunodeficiency virus (HIV) before and after combination antiretroviral therapy (cART). There were few reports about the same patients before and shortly after cART in FDG PET. It is well known that HIV-RNA levels decrease and cognitive impairments in patients with HIV tend to improve on neurocognitive performance tests 6 months after starting cART....
- Perioperative management with consumption of alcohol and nicotine in patients with hip and knee arthroplastyby Anne Postler on December 28, 2024
Excessive consumption of nicotine and alcohol has been proven to effect the organ system. Both stimulants are consumed in the population to a not insignificant extent. The question therefore arises as to what effect the consumption of nicotine and alcohol has on the complication rates and to what extent this should be reduced or stopped before performing a joint arthroplasty? A literature search was carried out to answer these questions. An increased risk of impaired wound healing and...
- Factors Associated with Tobacco Cessation Services Request Among Users of an Online Self-Screening Questionnaireby Norberto F Hernández-Llanes on December 28, 2024
CONCLUSIONS: These results suggest the random forest algorithm's effectiveness in predicting potential cessation service users. Furthermore, the predictor variables provide valuable insights for designing targeted prevention and awareness campaigns, potentially leading to improved campaign effectiveness and more individuals receiving cessation support.